- Home
- TARA vs LTRX Comparison
TARA vs LTRX Comparison
Compare TARA & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | LTRX |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | 352 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 236.4M |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TARA | LTRX |
|---|---|---|
| Price | $3.97 | $5.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $24.40 | $6.50 |
| AVG Volume (30 Days) | 464.4K | ★ 737.5K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $122,923,000.00 |
| Revenue This Year | N/A | $1.12 |
| Revenue Next Year | N/A | $15.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.97 | $2.86 |
| 52 Week High | $7.82 | $8.75 |
Technical Indicators
Market Signals| Indicator | TARA | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 50.51 |
| Support Level | $3.69 | $5.60 |
| Resistance Level | $4.23 | $5.97 |
| Average True Range (ATR) | 0.16 | 0.31 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 41.74 | 65.26 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.